NO20005224D0 - BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse - Google Patents
BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelseInfo
- Publication number
- NO20005224D0 NO20005224D0 NO20005224A NO20005224A NO20005224D0 NO 20005224 D0 NO20005224 D0 NO 20005224D0 NO 20005224 A NO20005224 A NO 20005224A NO 20005224 A NO20005224 A NO 20005224A NO 20005224 D0 NO20005224 D0 NO 20005224D0
- Authority
- NO
- Norway
- Prior art keywords
- identification
- methods
- btk inhibitors
- inhibitors
- btk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/40—Y being a hydrogen or a carbon atom
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8209498P | 1998-04-17 | 1998-04-17 | |
US09/273,191 US6303652B1 (en) | 1998-08-21 | 1999-03-19 | BTK inhibitors and methods for their identification and use |
PCT/US1999/008556 WO1999054286A2 (en) | 1998-04-17 | 1999-04-19 | Btk inhibitors and methods for their identification and use |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005224D0 true NO20005224D0 (no) | 2000-10-17 |
NO20005224L NO20005224L (no) | 2000-12-18 |
Family
ID=26767041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005224A NO20005224L (no) | 1998-04-17 | 2000-10-17 | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1071658B1 (no) |
JP (1) | JP2002512216A (no) |
KR (1) | KR20010042804A (no) |
AT (1) | ATE269295T1 (no) |
AU (1) | AU3653099A (no) |
CA (1) | CA2328962A1 (no) |
DE (1) | DE69918089T2 (no) |
ES (1) | ES2222705T3 (no) |
HU (1) | HUP0102661A2 (no) |
IL (1) | IL139080A0 (no) |
MX (1) | MXPA00010150A (no) |
NO (1) | NO20005224L (no) |
WO (1) | WO1999054286A2 (no) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303652B1 (en) | 1998-08-21 | 2001-10-16 | Hughes Institute | BTK inhibitors and methods for their identification and use |
WO2002034251A1 (en) * | 2000-10-20 | 2002-05-02 | Parker Hughes Institute | Treatment of asthma with lfm analogues |
US6306897B1 (en) | 1999-03-19 | 2001-10-23 | Parker Hughes Institute | Calanolides for inhibiting BTK |
US7053117B2 (en) | 2001-05-16 | 2006-05-30 | Cytovia, Inc. | Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
TR200401209T4 (tr) | 1999-11-05 | 2004-07-21 | Cytovia, Inc. | Kaspazların aktivatörleri ve apoptoz endüserleri olarak yer değiştiren 4H-kromen ve analogları ile bunların kullanımı |
US6589992B2 (en) | 1999-11-30 | 2003-07-08 | Parker Hughes Institute | Inhibiting collagen-induced platelet aggregation |
JP2003516351A (ja) * | 1999-11-30 | 2003-05-13 | パーカー ヒューズ インスティテュート | コラーゲン誘導血小板凝集阻害剤 |
GB0005345D0 (en) * | 2000-03-06 | 2000-04-26 | Mathilda & Terence Kennedy Ins | Methods of treating sepsis septic shock and inflammation |
AU2002236692A1 (en) * | 2000-10-23 | 2002-05-21 | Bristol-Myers Squibb Company | Modulators of bruton's tyrosine kinase and bruton's tyrosine kinase, their identification and use |
ES2286267T3 (es) * | 2001-03-07 | 2007-12-01 | Telik, Inc. | Diarilureas sustituidas como estimuladoras de mediada por fas. |
EP1377291A2 (de) * | 2001-03-13 | 2004-01-07 | Protagen AG | 1-butansäuderivate wie z.b. carbomethoxypropionylcyanid oder leflunomidderivate und deren therapeutische anwendung |
DE10112924A1 (de) * | 2001-03-13 | 2002-10-02 | Erich Eigenbrodt | 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate |
US6858607B1 (en) | 2001-05-16 | 2005-02-22 | Cytovia, Inc. | 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
WO2002092076A1 (en) * | 2001-05-16 | 2002-11-21 | Cytovia, Inc. | Substituted coumarins and quinolines as caspases activators |
WO2003027276A2 (en) * | 2001-09-24 | 2003-04-03 | University Of Aarhus | Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia |
WO2003096982A2 (en) | 2002-05-16 | 2003-11-27 | Cytovia, Inc. | Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof |
AU2003230411A1 (en) | 2002-05-16 | 2003-12-02 | Cytovia, Inc. | Substituted 4-aryl-4h-pyrrolo(2,3-h)chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
CA2498045A1 (en) * | 2002-09-06 | 2004-03-25 | Schebo Biotech Ag | Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
AR045037A1 (es) | 2003-07-10 | 2005-10-12 | Aventis Pharma Sa | Tetrahidro-1h-pirazolo [3,4-c] piridinas sustituidas, composiciones que las contienen y su utilizacion. |
JP2008517059A (ja) * | 2004-10-19 | 2008-05-22 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 炎症性腸疾患を治療するための(z)−2−シアノ−3−ヒドロキシ−ブタ−2−エン酸−(4’−トリフルオロメチルフェニル)−アミドの使用 |
US20100160292A1 (en) * | 2006-09-11 | 2010-06-24 | Cgi Pharmaceuticals, Inc | Kinase Inhibitors, and Methods of Using and Identifying Kinase Inhibitors |
EP2081435B1 (en) * | 2006-09-22 | 2016-05-04 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
SI2134374T1 (sl) * | 2007-03-14 | 2014-03-31 | Bionsil S.R.L. In Liquidazione | Inhibitorji btk za rabo pri zdravljenju na kemoterapevtska zdravila rezistentnih epitelijskih tumorjev |
US20120101113A1 (en) | 2007-03-28 | 2012-04-26 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
CA2701275C (en) * | 2007-10-23 | 2016-06-21 | F. Hoffmann-La Roche Ag | Kinase inhibitors |
WO2009060835A1 (ja) * | 2007-11-05 | 2009-05-14 | Kyoto University | 新規ユビキリン結合性小分子 |
US8389757B2 (en) | 2008-06-05 | 2013-03-05 | Alembic Ltd. | Process for preparing teriflunomide |
EP3311818A3 (en) | 2008-07-16 | 2018-07-18 | Pharmacyclics, LLC | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors |
CN110172051B (zh) * | 2010-04-05 | 2023-03-07 | 复星弘创(苏州)医药科技有限公司 | IRE-1α抑制剂 |
WO2011153514A2 (en) | 2010-06-03 | 2011-12-08 | Pharmacyclics, Inc. | The use of inhibitors of bruton's tyrosine kinase (btk) |
WO2013010136A2 (en) | 2011-07-13 | 2013-01-17 | Pharmacyclics, Inc. | Inhibitors of bruton's tyrosine kinase |
US8377946B1 (en) | 2011-12-30 | 2013-02-19 | Pharmacyclics, Inc. | Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors |
US9365566B2 (en) | 2012-03-27 | 2016-06-14 | Takeda Pharmaceutical Company Limited | Cinnoline derivatives |
NZ702548A (en) | 2012-06-04 | 2015-11-27 | Pharmacyclics Llc | Crystalline forms of a bruton’s tyrosine kinase inhibitor |
JP6575950B2 (ja) | 2012-07-24 | 2019-09-18 | ファーマサイクリックス エルエルシー | Bruton型チロシンキナーゼ(Btk)阻害剤に対する耐性を伴う変異 |
MX2015006168A (es) | 2012-11-15 | 2015-08-10 | Pharmacyclics Inc | Compuestos de pirrolopirimidina como inhibidores de quinasas. |
JP6307515B2 (ja) * | 2012-11-28 | 2018-04-04 | コーニング インコーポレイテッド | 肝細胞機能の増強のための細胞培養培地 |
JO3377B1 (ar) | 2013-03-11 | 2019-03-13 | Takeda Pharmaceuticals Co | مشتقات بيريدينيل وبيريدينيل مندمج |
CA2901542C (en) * | 2013-04-02 | 2018-02-13 | F. Hoffmann-La Roche Ag | Inhibitors of bruton's tyrosine kinase |
JP6800750B2 (ja) | 2013-08-02 | 2020-12-16 | ファーマサイクリックス エルエルシー | 固形腫瘍の処置方法 |
EP2832358A1 (en) * | 2013-08-02 | 2015-02-04 | Bionsil S.r.l. | Pharmaceutical kit for use in the treatment of colon and colorectal cancer |
CA2920534A1 (en) | 2013-08-12 | 2015-02-19 | Pharmacyclics Llc | Methods for the treatment of her2 amplified cancer |
PE20160560A1 (es) | 2013-09-30 | 2016-06-09 | Pharmacyclics Llc | DERIVADOS DE PIRAZOLO[3,4-d]PIRIMIDIN COMO INHIBIDORES IRREVERSIBLES DE LA TIROSINA CINASA DE BRUTON (BTK) |
EP3079682A4 (en) | 2013-12-13 | 2017-08-30 | Dana-Farber Cancer Institute, Inc. | Methods to treat lymphoplasmacytic lymphoma |
WO2015089479A1 (en) | 2013-12-13 | 2015-06-18 | Dana-Farber Cancer Institute, Inc. | Methods to treat lymphoplasmacytic lymphoma |
US9885086B2 (en) | 2014-03-20 | 2018-02-06 | Pharmacyclics Llc | Phospholipase C gamma 2 and resistance associated mutations |
CN105272882B (zh) * | 2014-07-23 | 2019-05-31 | 欣凯医药化工中间体(上海)有限公司 | 一种环保简便制备泰瑞米特的方法 |
US9533991B2 (en) | 2014-08-01 | 2017-01-03 | Pharmacyclics Llc | Inhibitors of Bruton's tyrosine kinase |
JP2017523206A (ja) | 2014-08-07 | 2017-08-17 | ファーマサイクリックス エルエルシー | ブルトン型チロシンキナーゼ阻害剤の新規製剤 |
CA2965178C (en) | 2014-10-22 | 2023-09-26 | Dana-Farber Cancer Institute, Inc. | Thiazolyl-containing compounds for treating proliferative diseases |
BR122023020985A2 (pt) | 2015-03-03 | 2023-12-26 | Pharmacyclics Llc | Formulação de comprimido sólido de um inibidor de tirosina quinase de bruton |
AU2017240609B2 (en) | 2016-03-31 | 2021-07-15 | Takeda Pharmaceutical Company Limited | Isoquinolinyl triazolone complexes |
WO2018111902A1 (en) | 2016-12-12 | 2018-06-21 | Multivir Inc. | Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases |
AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
US20220401436A1 (en) | 2019-11-08 | 2022-12-22 | INSERM (Institute National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2555685A1 (de) * | 1975-12-11 | 1977-06-23 | Hoechst Ag | Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel |
KR100188801B1 (ko) * | 1990-05-18 | 1999-06-01 | 엥겔하르트 라피체 | 이속사졸-4카복스아미드 및 하이드록시알킬리덴 시아노아세트아미드 및 이들 화합물을 함유하는 약제학적 조성물 |
CA2080554A1 (en) * | 1991-10-15 | 1993-04-16 | Mitsubishi Chemical Corporation | Styrene derivatives |
GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
AU5958394A (en) * | 1992-12-23 | 1994-07-19 | Smithkline Beecham Corporation | Coumarin derivatives as retroviral inhibitors |
GB9322781D0 (en) * | 1993-11-04 | 1993-12-22 | Roussel Lab Ltd | Aromatic amides |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5489697A (en) * | 1994-08-03 | 1996-02-06 | Medichem Research, Inc. | Method for the preparation of (+)-calanolide A and intermediates thereof |
US5608085A (en) * | 1995-02-27 | 1997-03-04 | The University Of Tennessee Research Corporation | Synthesis of optically active calanolides A and B and enantiomers and related compounds |
WO1996031206A2 (en) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
IT1289238B1 (it) * | 1996-12-10 | 1998-09-29 | Bio S S P A Ora Bio S S R L | Composizioni farmaceutiche per il trattamento di infezioni virali comprendenti una 4 arilcumarina |
-
1999
- 1999-04-19 JP JP2000544627A patent/JP2002512216A/ja active Pending
- 1999-04-19 WO PCT/US1999/008556 patent/WO1999054286A2/en not_active Application Discontinuation
- 1999-04-19 CA CA002328962A patent/CA2328962A1/en not_active Abandoned
- 1999-04-19 IL IL13908099A patent/IL139080A0/xx unknown
- 1999-04-19 KR KR1020007011551A patent/KR20010042804A/ko not_active Application Discontinuation
- 1999-04-19 DE DE69918089T patent/DE69918089T2/de not_active Expired - Fee Related
- 1999-04-19 AU AU36530/99A patent/AU3653099A/en not_active Abandoned
- 1999-04-19 AT AT99918673T patent/ATE269295T1/de not_active IP Right Cessation
- 1999-04-19 MX MXPA00010150A patent/MXPA00010150A/es unknown
- 1999-04-19 EP EP99918673A patent/EP1071658B1/en not_active Expired - Lifetime
- 1999-04-19 ES ES99918673T patent/ES2222705T3/es not_active Expired - Lifetime
- 1999-04-19 HU HU0102661A patent/HUP0102661A2/hu unknown
-
2000
- 2000-10-17 NO NO20005224A patent/NO20005224L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69918089T2 (de) | 2005-07-14 |
WO1999054286A3 (en) | 2000-05-04 |
JP2002512216A (ja) | 2002-04-23 |
HUP0102661A2 (hu) | 2001-11-28 |
EP1071658A2 (en) | 2001-01-31 |
WO1999054286A2 (en) | 1999-10-28 |
AU3653099A (en) | 1999-11-08 |
ATE269295T1 (de) | 2004-07-15 |
IL139080A0 (en) | 2001-11-25 |
NO20005224L (no) | 2000-12-18 |
CA2328962A1 (en) | 1999-10-28 |
ES2222705T3 (es) | 2005-02-01 |
DE69918089D1 (de) | 2004-07-22 |
KR20010042804A (ko) | 2001-05-25 |
EP1071658B1 (en) | 2004-06-16 |
MXPA00010150A (es) | 2002-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005224D0 (no) | BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse | |
DE60007095D1 (de) | Calanolide zur hemmung von btk | |
CY1112687T1 (el) | Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες | |
TR200100054T2 (tr) | Paroksetin metansülfonat | |
DK1268431T3 (da) | 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer | |
DE60010098D1 (de) | 28-epirapaloge | |
PT1202724E (pt) | Metodo para tratamento da dor cronica utilizando inibidores mek | |
DK1355889T3 (da) | Substituerede triazoldiaminderivater som kinaseinhibitorer | |
ID30460A (id) | Inhibitor-inhibitor protein siklik tirosin kinase | |
DK1171417T3 (da) | Fremgangsmåde til fremstilling af 3-aryloxy-3-arylpropylaminer og mellemprodukter deraf | |
ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
BR0214309A (pt) | Derivados aril-1,4-pirazina substituìdos | |
ATE231872T1 (de) | Thiazolopyrimidinderivate | |
BR0311318A (pt) | Inibidores de peptìdeo desformilase | |
ATE240303T1 (de) | 1,2,4-triazol-3-thion verbindungen | |
NO20013853L (no) | Heteroarylamidiner, metylamidiner og guanidiner som proteaseinhibitorer | |
DK1441761T3 (da) | Fremgangsmåder til forebyggelse og behandling af flavivirus-infektion hos dyr | |
DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
NO20033921L (no) | Inhibitor av monoaminopptak | |
BR0112600A (pt) | Compostos calcilìticos | |
NO20025281L (no) | Peptid-deformylase-inhibitorer | |
DE60207833D1 (de) | Peptiddeformylase-hemmer | |
ATE322898T1 (de) | Inhibitoren von mycobakterien | |
BR0110205A (pt) | Inibidores de peptìdeo deformilase | |
ATE514683T1 (de) | Peptid-deformylase-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |